Home › Funds › RA CAPITAL MANAGEMENT, L.P. › BCAX

RA CAPITAL MANAGEMENT, L.P. position in BCAX

BICARA THERAPEUTICS INC · Health Care

RA CAPITAL MANAGEMENT, L.P. reported holding 7,255,993 shares of BCAX (BICARA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$215.4M, representing 1.87% of its reported portfolio and ranking #11 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed BCAX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)7.26M sh
Reported value held$215.43M
Portfolio Weight1.87%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How RA CAPITAL MANAGEMENT, L.P.'s BCAX position evolved

RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in BCAX in Q3 2024 at 6,955,993 shares (US$177.2M). The position peaked in Q2 2026 at 7,255,993 shares, worth US$215.4M. Across 8 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 7,255,993 shares valued at US$215.4M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 6.96M $177.17M New
Q4 2024 6.96M $121.17M Hold
Q1 2025 6.96M $90.64M Hold
Q2 2025 6.96M $64.62M Hold
Q3 2025 6.96M $109.84M Hold
Q4 2025 6.96M $117.07M Hold
Q1 2026 7.26M $144.32M Add
Q2 2026 7.26M $215.43M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCAX and 13F data

BCAX (BICARA THERAPEUTICS INC) is a Health Care company. 58 other funds we track also report a position in BCAX — the largest reported positions include Siren, L.L.C. (US$166.4M), Vestal Point Capital, LP (US$155.9M), Deep Track Capital, LP (US$121.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCAX

All BCAX fund holders →

FAQ

How long has RA CAPITAL MANAGEMENT, L.P. held BCAX?

RA CAPITAL MANAGEMENT, L.P. has disclosed BCAX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is RA CAPITAL MANAGEMENT, L.P.'s current position in BCAX?

As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 7.26M shares of BCAX (BICARA THERAPEUTICS INC), valued at $215.43M, representing 1.87% of its reported portfolio and ranking #11.

Has RA CAPITAL MANAGEMENT, L.P. been buying or selling BCAX?

In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. held unchanged its position in BCAX. The position peaked in Q2 2026 at 7.26M shares.

Which other funds hold BCAX?

Other major institutional holders of BCAX include Siren, L.L.C., Vestal Point Capital, LP, Deep Track Capital, LP, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.